BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19014871)

  • 1. DMARDS and infections in rheumatoid arthritis.
    Caporali R; Caprioli M; Bobbio-Pallavicini F; Montecucco C
    Autoimmun Rev; 2008 Dec; 8(2):139-43. PubMed ID: 19014871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
    J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
    Wolfe F; Caplan L; Michaud K
    Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
    Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.
    Bernatsky S; Hudson M; Suissa S
    Rheumatology (Oxford); 2007 Jul; 46(7):1157-60. PubMed ID: 17478469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
    Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D
    Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
    Atzeni F; Boiardi L; Sallì S; Benucci M; Sarzi-Puttini P
    Expert Rev Clin Immunol; 2013 Jul; 9(7):649-57. PubMed ID: 23899235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
    Karanikolas G; Charalambopoulos D; Vaiopoulos G; Andrianakos A; Rapti A; Karras D; Kaskani E; Sfikakis PP
    Rheumatology (Oxford); 2008 Sep; 47(9):1384-8. PubMed ID: 18603660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antirheumatic drug use and the risk of acute myocardial infarction.
    Suissa S; Bernatsky S; Hudson M
    Arthritis Rheum; 2006 Aug; 55(4):531-6. PubMed ID: 16874796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of conventional disease-modifying anti-rheumatic drugs in established RA.
    Jurgens MS; Jacobs JW; Bijlsma JW
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):523-33. PubMed ID: 22137922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment?
    Pieringer H; Stuby U; Biesenbach G
    Semin Arthritis Rheum; 2007 Apr; 36(5):278-86. PubMed ID: 17204310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
    Suissa S; Hudson M; Ernst P
    Arthritis Rheum; 2006 May; 54(5):1435-9. PubMed ID: 16645972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in rheumatoid arthritis.
    Ranganathan P
    Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide-associated pancytopenia with or without methotrexate.
    Chan J; Sanders DC; Du L; Pillans PI
    Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.